Medical Experts Want Caffeine Limits in Drinks

A group of doctors has urged the U.S. Food and Drug Administration to take more action to protect teenagers from the risk of ingesting too much caffeine from popular energy drinks.

An 18-member group of medical experts said that there was evidence in scientific literature that has been published that the levels of caffeine in the popular energy drinks pose potential serous health risks.

The group said in their letter to the FDA that manufacturers of energy drinks have not proven that the ingredients of their different products are safe, especially in the way they go about marketing their products towards teens and young children.

The medical experts want the U.S. regulatory agency to restrict the amount of caffeine in the drinks and mandate that the makers of the drinks include the amount of caffeine that is in their product on its product contents label.

Manufacturers of energy drinks contend that their products are safe and the level of caffeine in the drinks is equal to other beverages that are caffeinated, like coffee.

Adults, said the FDA, are able to drink safely nearly 400 milligrams of caffeine each day. However, some experts warn that over 600 mg can be ingested without side effects.

However, children and teenager should drink less caffeine than those amounts according to the health experts. At this point however, it is still not known what is the amount that is safe for youngsters to consume. The group says the drinks’ manufacturers are marketing their product directly to teenagers.

Problems with health linked to these energy drinks have acted to increase the number of emergency room visits, over the past few years.

 



Latest News

SINOVATE Market Cap Hits $1.87 Million
SINOVATE Market Cap Hits $1.87 Million
Bodhi  Price Reaches $0.0419 on Major Exchanges
Bodhi Price Reaches $0.0419 on Major Exchanges
$53.53 Million in Sales Expected for Bluerock Residential Growth REIT, Inc.  This Quarter
$53.53 Million in Sales Expected for Bluerock Residential Growth REIT, Inc. This Quarter
ANI Pharmaceuticals Inc  Receives $84.25 Consensus PT from Brokerages
ANI Pharmaceuticals Inc Receives $84.25 Consensus PT from Brokerages
Analysts Set Eagle Materials, Inc.  Price Target at $93.05
Analysts Set Eagle Materials, Inc. Price Target at $93.05
STRAKS Price Reaches $0.0023 on Exchanges
STRAKS Price Reaches $0.0023 on Exchanges


 
© 2006-2019 Zolmax.